Multimedia Release

Prooxidants May Fix Metabolic Defect in Arthritis-Driving T Cells

Reports and Proceedings

American Association for the Advancement of Science (AAAS)

Prooxidants May Fix Metabolic Defect in Arthritis-Driving T Cells

image: Rheumatoid arthritis is a common autoimmune disease involving joint inflammation and damage. Researchers have uncovered a metabolic defect in T cells from rheumatoid arthritis patients, which may be corrected by replenishing T cells' reactive oxygen species supply. This material relates to a paper that appeared in March 23, 2016 issue of Science Translational Medicine, published by AAAS. The paper, by author at institution in location, and colleagues was titled, "Restoring oxidant signaling suppresses proarthritogenic T cell effector functions in rheumatoid arthritis." view more 

Credit: V. Altounian / <i>Science Translational Medicine</i> (2016)


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.